Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (GU5)
FSX
1.51
-0.10 (-6.21%)
Closed
Aug 24, 2026
Day's Range
1.511.51
52 wk Range
1.512.30
Financial Statements - GU5 - Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Revenue
77.65B▲ 3.6%
Net Income
3.06B▲ 2.0%Net Margin 3.9%
EBITDA
5.11B▼ 4.6%
Free Cash Flow
-1.47B▼ 163.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 77.65B | 74.99B | 75.51B | 70.78B | 69.01B | 61.67B |
| Cost of Goods | 65.04B | 62.47B | 61.32B | 57.51B | 55.78B | 51.23B |
| Gross Profit | 12.61B | 12.52B | 14.18B | 13.27B | 13.23B | 10.44B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 3.53B | 3.77B | 4.87B | 4.54B | 4.38B | 3.47B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 3.68B | 3.60B | 5.11B | 5.04B | 4.72B | 3.73B |
| Income Tax | 629.21M | 606.84M | 851.17M | 789.87M | 754.08M | 647.45M |
| Net Income | 3.06B | 3B | 4.25B | 4.25B | 3.96B | 3.09B |
| EPS Basic | 1.834869 | 1.744072 | 2.495 | 2.44 | 2.288 | 1.793 |
| EPS Diluted | 1.834869 | 1.744072 | 2.495 | 2.44 | 2.288 | 1.793 |
| Basic Shares Outstanding | - | 1.62B | 12.85B | 12.29B | 12.29B | 12.29B |
| Diluted Shares Outstanding | - | 1.62B | 12.85B | 12.29B | 12.29B | 12.29B |
| Ebit | 4.09B | 4.02B | 5.55B | 5.47B | 5.14B | 4.03B |
| Ebitda | 5.11B | 5.36B | 6.53B | 6.28B | 5.74B | 4.82B |
| Net Income Continuous Operations | 3.06B | 3B | 4.25B | 4.25B | 3.96B | 3.09B |
| Minority Interests | -77.59M | -165.23M | -203.64M | -286.84M | -249.10M | -176.38M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
